Trojandt, Stefanie; Bellinghausen, Iris; Reske-Kunz, Angelika B. et al.
Tumor-derived immuno-modulators induce overlapping pro-tolerogenic gene expression signatures in human dendritic cellsHUMAN IMMUNOLOGY. Bd. 77. H. 12. 2016 S. 1223-1231
Zimmer, S.; Oberhag, A. Peveling; Weber, A. et al.
Unique coexistence of cold and solar urticaria and its efficient treatmentBRITISH JOURNAL OF DERMATOLOGY. Bd. 174. H. 5. 2016 S. 1150-1152
Selmi, Abderraouf; Vascotto, Fulvia; Kautz-Neu, Kordula et al.
Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in miceCANCER IMMUNOLOGY IMMUNOTHERAPY. Bd. 65. H. 9. 2016 S. 1075-1083
Huebner, Jutta; Mohr, Peter; Simon, Jan-Christoph et al.
Use of complementary medicine in metastatic melanoma patients treated with ipilimumab within a clinical trialJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. H. 5. 2016 S. 508-513
Shen, Limei; Krauthaeuser, Susanne; Fischer, Karl et al.
Vaccination with trifunctional nanoparticles that address CD8(+) dendritic cells inhibits growth of established melanomaNANOMEDICINE. Bd. 11. H. 20. 2016 S. 2647-2662
Moinzadeh, Pia; Riemekasten, Gabriela; Siegert, Elise et al.
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 PatientsJOURNAL OF RHEUMATOLOGY. Bd. 43. H. 1. 2016 S. 66-74
Saloga, Joachim; Grabbe, Stephan
27. Mainzer Allergy-WorkshopALLERGO JOURNAL. Bd. 24. H. 1. 2015 S. 42-43
Proebstle, Thomas M.; Moehler, Thomas
A longitudinal single-center cohort study on the prevalence and risk of accessory saphenous vein reflux after radiofrequency segmental thermal ablation of great saphenous veinsJOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS. Bd. 3. H. 3. 2015 S. 265-269
Ugurel, S.; Loquai, C.; Kaehler, K. et al.
A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survivalANNALS OF ONCOLOGY. Bd. 26. H. 3. 2015 S. 573-582
Hersh, E. M.; Del Vecchio, M.; Brown, M. P. et al.
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naive patients with metastatic melanomaANNALS OF ONCOLOGY. Bd. 26. H. 11. 2015 S. 2267-2274